Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance

Snyder W, Report of Task Force on reference man. Oxford: Pergamon Press for the International Commission on Radiological Protection; 1975. Blaak, 1994, beta-Adrenergic stimulation of skeletal muscle metabolism in relation to weight reduction in obese men, American Journal of Physiology, 267, E316 Connacher, 1991, Effect of adrenaline infusion on fatty acid and glucose turnover in lean and obese human subjects in the post-absorptive and fed states, Clinical Science (London), 81, 635, 10.1042/cs0810635 Colberg, 1995, Skeletal muscle utilization of free fatty acids in women with visceral obesity, Journal of Clinical Investigation, 95, 1846, 10.1172/JCI117864 Astrup, 1994, Failure to increase lipid oxidation in response to increasing dietary fat content in formerly obese women, American Journal of Physiology, 266, E592 Zurlo, 1990, Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ, American Journal of Physiology, 259, E650 Blaak, 2004, Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus, The Proceedings of the Nutrition Society, 63, 323, 10.1079/PNS2004361 Kim, 2000, Lipid oxidation is reduced in obese human skeletal muscle, American Journal of Physiology, Endocrinology and Metabolism, 279, E1039, 10.1152/ajpendo.2000.279.5.E1039 Hulver, 2003, Skeletal muscle lipid metabolism with obesity, American Journal of Physiology, Endocrinology and Metabolism, 284, E741, 10.1152/ajpendo.00514.2002 Astrup, 1996, Defects in substrate oxidation involved in the predisposition to obesity, The Proceedings of the Nutrition Society, 55, 817, 10.1079/PNS19960081 Froidevaux, 1993, Energy expenditure in obese women before and during weight loss, after refeeding, and in the weight-relapse period, American Journal of Clinical Nutrition, 57, 35, 10.1093/ajcn/57.1.35 Ranneries, 1998, Fat metabolism in formerly obese women, American Journal of Physiology, 274, E155 Ezell, 1999, Substrate oxidation and availability during acute exercise in non-obese, obese, and post-obese sedentary females, International Journal of Obesity and Related Metabolic Disorders, 23, 1047, 10.1038/sj.ijo.0801037 Rabinowitz, 1961, Forearm metabolism in obesity and its response to intra-arterial insulin. Evidence for adaptive hyperinsulinism, Lancet, 2, 690, 10.1016/S0140-6736(61)92838-0 Bogardus, 1985, Relationship between degree of obesity and in vivo insulin action in man, American Journal of Physiology, 248, E286 Evans, 1984, Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography, Journal of Clinical Investigation, 74, 1515, 10.1172/JCI111565 Randle, 1998, Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years, Diabetes/Metabolism Reviews, 14, 263, 10.1002/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C Dresner, 1999, Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity, Journal of Clinical Investigation, 103, 253, 10.1172/JCI5001 Boden, 2001, Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects, Diabetes, 50, 1612, 10.2337/diabetes.50.7.1612 Ellis, 2000, Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle, American Journal of Physiology Endocrinology and Metabolism, 279, E554, 10.1152/ajpendo.2000.279.3.E554 Itani, 2002, Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α, Diabetes, 51, 2005, 10.2337/diabetes.51.7.2005 Mensink, 2001, Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes, Diabetes, 50, 2548, 10.2337/diabetes.50.11.2548 Turpeinen, 1999, Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid, Diabetes, 48, 1245, 10.2337/diabetes.48.6.1245 Kelley, 1994, Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus, Journal of Clinical Investigation, 94, 2349, 10.1172/JCI117600 Blaak, 2000, utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle, American Journal of Physiology Endocrinology and Metabolism, 279, E146, 10.1152/ajpendo.2000.279.1.E146 Blaak, 2002, The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects, Diabetes, 51, 784, 10.2337/diabetes.51.3.784 Kelley, 2000, Fuel selection in human skeletal muscle in insulin resistance: a reexamination, Diabetes, 49, 677, 10.2337/diabetes.49.5.677 Felber, 1987, Role of lipid oxidation in the pathogenesis of insulin resistance of obesity and type II diabetes, Diabetes, 36, 1341, 10.2337/diabetes.36.11.1341 van der Vusse, 2002, Critical steps in cellular fatty acid uptake and utilization, Molecular and Cellular Biochemistry, 239, 9, 10.1023/A:1020538119691 Jensen, 1989, Influence of body fat distribution on free fatty acid metabolism in obesity, Journal of Clinical Investigation, 83, 1168, 10.1172/JCI113997 Schiffelers, 2001, beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men, Journal of Clinical Endocrinology and Metabolism, 86, 2191, 10.1210/jc.86.5.2191 Reynisdottir, 1994, Multiple lipolysis defects in the insulin resistance (metabolic) syndrome, Journal of Clinical Investigation, 93, 2590, 10.1172/JCI117271 Reynisdottir, 1995, Effects of weight reduction on the regulation of lipolysis in adipocytes of women with upper-body obesity, Clinical Sciences (London), 89, 421, 10.1042/cs0890421 Schiffelers, 2001, The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men, International Journal of Obesity and Related Metabolic Disorders, 25, 33, 10.1038/sj.ijo.0801528 Glatz, 2001, Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake, Journal of Molecular Neuroscience, 16, 123, 10.1385/JMN:16:2-3:123 Simoneau, 1999, Markers of the capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance, and obesity and effects of weight loss, Faseb Journal, 13, 2051, 10.1096/fasebj.13.14.2051 Glatz, 2003, Cytoplasmic fatty acid-binding protein facilitates fatty acid utilization by skeletal muscle, Acta Physiologica Scandinavica, 178, 367, 10.1046/j.1365-201X.2003.01166.x Aitman, 1999, Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats, Nature Genetics, 21, 76, 10.1038/5013 Coburn, 2000, Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice, Journal of Biological Chemistry, 275, 32523, 10.1074/jbc.M003826200 Hajri, 2001, Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy, Journal of Biological Chemistry, 276, 23661, 10.1074/jbc.M100942200 Wilmsen, 2003, Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects, American Journal of Physiology Endocrinology and Metabolism, 285, E354, 10.1152/ajpendo.00491.2001 Luiken, 2003, Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling, Diabetes, 52, 1627, 10.2337/diabetes.52.7.1627 Luiken, 2002, Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane, American Journal of Physiology Endocrinology and Metabolism, 282, E491, 10.1152/ajpendo.00419.2001 Luiken, 2001, Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats, Journal of Biological Chemistry, 276, 40567, 10.1074/jbc.M100052200 Bonen, 2004, Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36, Faseb Journal, 18, 1144, 10.1096/fj.03-1065fje Gaster, 2004, Reduced lipid oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin: evidence from cultured myotubes, Diabetes, 53, 542, 10.2337/diabetes.53.3.542 Saha, 1997, Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle, American Journal of Physiology, 272, E641 Schrauwen, 2002, The effect of a 3-month low-intensity endurance training program on fat oxidation and acetyl-CoA carboxylase-2 expression, Diabetes, 51, 2220, 10.2337/diabetes.51.7.2220 Mensink, 2003, Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance, Diabetologia, 46, 1082, 10.1007/s00125-003-1152-2 Sidossis, 1996, Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed, American Journal of Physiology, 270, E733 Kelley, 1999, Skeletal muscle fatty acid metabolism in association with insulin resisitance, obesity and weight loss, American Journal of Physiology, 277, E1130 Mandarino, 1996, Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM, American Journal of Physiology, 270, E463 Rasmussen, 2002, Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle, Journal of Clinical Investigation, 110, 1687, 10.1172/JCI0215715 Kelley, 2002, Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes, Diabetes, 51, 2944, 10.2337/diabetes.51.10.2944 Ritov, 2005, Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes, Diabetes, 54, 8, 10.2337/diabetes.54.1.8 Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance, Science, 300, 1140, 10.1126/science.1082889 Petersen, 2004, Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, New England Journal of Medicine, 350, 664, 10.1056/NEJMoa031314 Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nature Genetics, 34, 267, 10.1038/ng1180 Patti, 2003, Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1, Proceedings of the National Academic Science USA, 100, 8466, 10.1073/pnas.1032913100 Schrauwen, 2004, Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes, Diabetes, 53, 1412, 10.2337/diabetes.53.6.1412 Lowell, 2005, Mitochondrial dysfunction and type 2 diabetes, Science, 307, 384, 10.1126/science.1104343